Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
He has published more than 100 research papers in several prestigious national and international journals
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
Health resources – both human and material are precious assets to the society and a robust health care administration and management system ensures their effective utilization: Dr Bharati Pravin Pawar
She joins Enveda from Gilead Sciences
Subscribe To Our Newsletter & Stay Updated